Subgroups of Patients with Young-onset Type 2 Diabetes in India Reveal Insulin Deficiency As a Major Driver
Overview
Authors
Affiliations
Aim/hypothesis: Five subgroups were described in European diabetes patients using a data driven machine learning approach on commonly measured variables. We aimed to test the applicability of this phenotyping in Indian individuals with young-onset type 2 diabetes.
Methods: We applied the European-derived centroids to Indian individuals with type 2 diabetes diagnosed before 45 years of age from the WellGen cohort (n = 1612). We also applied de novo k-means clustering to the WellGen cohort to validate the subgroups. We then compared clinical and metabolic-endocrine characteristics and the complication rates between the subgroups. We also compared characteristics of the WellGen subgroups with those of two young European cohorts, ANDIS (n = 962) and DIREVA (n = 420). Subgroups were also assessed in two other Indian cohorts, Ahmedabad (n = 187) and PHENOEINDY-2 (n = 205).
Results: Both Indian and European young-onset type 2 diabetes patients were predominantly classified into severe insulin-deficient (SIDD) and mild obesity-related (MOD) subgroups, while the severe insulin-resistant (SIRD) and mild age-related (MARD) subgroups were rare. In WellGen, SIDD (53%) was more common than MOD (38%), contrary to findings in Europeans (Swedish 26% vs 68%, Finnish 24% vs 71%, respectively). A higher proportion of SIDD compared with MOD was also seen in Ahmedabad (57% vs 33%) and in PHENOEINDY-2 (67% vs 23%). Both in Indians and Europeans, the SIDD subgroup was characterised by insulin deficiency and hyperglycaemia, MOD by obesity, SIRD by severe insulin resistance and MARD by mild metabolic-endocrine disturbances. In WellGen, nephropathy and retinopathy were more prevalent in SIDD compared with MOD while the latter had higher prevalence of neuropathy.
Conclusions /interpretation: Our data identified insulin deficiency as the major driver of type 2 diabetes in young Indians, unlike in young European individuals in whom obesity and insulin resistance predominate. Our results provide useful clues to pathophysiological mechanisms and susceptibility to complications in type 2 diabetes in the young Indian population and suggest a need to review management strategies.
Lessons Learned From Epidemiology of Type 2 Diabetes in South Asians: Kelly West Award Lecture 2024.
Mohan V Diabetes Care. 2025; 48(2):153-163.
PMID: 39841965 PMC: 11770170. DOI: 10.2337/dci24-0046.
Young-Onset Diabetes in Sri Lanka: Experience From the Developing World.
Arambewela M, Mathara Diddhenipothage S, Subasinghe C, Wijenayake U, Jayakody S, Ratnayake G J Diabetes Res. 2024; 2024():7557153.
PMID: 39720308 PMC: 11668545. DOI: 10.1155/jdr/7557153.
Atal S, Bohra A, Kalra S, Balakrishnan S, Joshi R J Family Med Prim Care. 2024; 13(10):4244-4251.
PMID: 39629445 PMC: 11610898. DOI: 10.4103/jfmpc.jfmpc_87_24.
Wang K, Qian Q, Bian C, Sheng P, Zhu L, Teng S Diabetes Ther. 2024; 16(1):89-102.
PMID: 39556310 PMC: 11759728. DOI: 10.1007/s13300-024-01667-7.
Tripathi P, Vyawahare A, Kadam N, Tiwari D, Biswas M, Kathrikolly T Sci Rep. 2024; 14(1):20260.
PMID: 39217248 PMC: 11366003. DOI: 10.1038/s41598-024-71126-7.